Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer.

MLA

Mahajan, Ujjwal M., et al. “Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer.” JNCI Cancer Spectrum, vol. 4, no. 1, Aug. 2019, p. pkz060. EBSCOhost, https://doi.org/10.1093/jncics/pkz060.

APA

Mahajan, U. M., Goni, E., Langhoff, E., Li, Q., Costello, E., Greenhalf, W., Kruger, S., Ormanns, S., Halloran, C., Ganeh, P., Marron, M., Lämmerhirt, F., Zhao, Y., Beyer, G., Weiss, F.-U., Sendler, M., Bruns, C. J., Kohlmann, T., Kirchner, T., … Mayerle, J. (2019). Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer. JNCI Cancer Spectrum, 4(1), pkz060. https://doi.org/10.1093/jncics/pkz060

Chicago

Mahajan, Ujjwal M, Elisabetta Goni, Enno Langhoff, Qi Li, Eithne Costello, William Greenhalf, Stephan Kruger, et al. 2019. “Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer.” JNCI Cancer Spectrum 4 (1): pkz060. doi:10.1093/jncics/pkz060.